Suchergebnisse - "Hu, Yi"

PubPharm (52)

1

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

enthalten in: The New England journal of medicine | 2023

von Planchard, D. | Jänne, P. | Cheng, Y. | +119

CommentIn: N Engl J Med. 2024 Feb 1;390(5):478. - PMID 38294983

2

Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer

enthalten in: Cancer discovery | 2023

von Weng, W. | Meng, T. | Zhao, Q. | +20

CommentIn: Cancer Discov. 2023 Apr 3;13(4):817-818. - PMID 37009702

3

Indole diketopiperazine alkaloids and aromatic polyketides from the Antarctic fungus Penicillium sp. SCSIO 05705

enthalten in: Natural product research | 2023

von Hu, Y. | Chen, W. | Song, M. | +5

4

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

enthalten in: The New England journal of medicine | 2022

von Forde, P. | Spicer, J. | Lu, S. | +127

CommentIn: N Engl J Med. 2022 May 26;386(21):2050-2051. - PMID 35403840

5

Safety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer : a phase 1 dose-escalation and dose-expansion trial

enthalten in: Signal transduction and targeted therapy | 2022

von Shi, Y. | Fang, J. | Hao, X. | +26

6

Response to first-line treatment predicts progression-free survival benefit of small-cell lung cancer patients treated with anlotinib

enthalten in: Cancer medicine | 2021

von Qin, B. | Xin, L. | Hou, Q. | +6

7

One-Pot Preparation of Peptide-Doped Metal-Amino Acid Framework for General Encapsulation and Targeted Delivery

enthalten in: ACS applied materials & interfaces | 2021

von Mugaka, B. | Zhang, S. | Li, R. | +6

8

RING finger protein 38 induces the drug resistance of cisplatin in non-small-cell lung cancer

enthalten in: Cell biology international | 2021

von Wu, C. | Chen, L. | Tao, H. | +2

9

Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

enthalten in: Cancer research | 2021

von Hu, Y. | Yang, C. | Amorim, T. | +25

10

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

enthalten in: Cancer research | 2020

von Hu, Y. | Liu, H. | Fang, C. | +19

1
2
3
4
5
6
Nächster »
[6]